Company intelligence / Profile preview

Chronimed

Minnetonka, Minnesota, United States

Ownership: Private
Employees: ~330
Development stage: Other

Overview

Chronimed was a leading provider of specialty pharmacy services and diagnostics addressing chronic and complex conditions; the company was known for significant growth and expanding its reach via disease management and specialty distribution.

Therapeutic areas: NephrologyEndocrinologyWomen's HealthInfectious DiseasesNeurologyRare DiseasesHematologyOncology
Modalities: Small moleculeBiologicDiagnostic device
Industry: Biotech

Partnerships

Prudential Insurance Company (distribution channel)Cell Robotics (Lasette device distribution)

Beyond the preview

Go deeper on Chronimed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chronimed.

Explore the full profile